Global Hemodynamic Monitoring Market valued at $1.04 billion (2021), is projected to witness a decent growth of 6% by 2026

Uncontrolled perturbations in circulatory function during surgery can lead to tissue hypoxia, resulting in perioperative morbidity and mortality. Hemodynamic monitoring provides information about the adequacy of a patient's circulation, perfusion, and oxygenation of the tissues and organ systems delivering safe anesthetic care.

Technological Advancements in Hemodynamic Monitoring Systems to trigger the Market Demand

Constant innovations in critical patient care have enabled to develop reliable hemodynamic monitoring systems featuring non-invasive technology and expanded parameters such as continuous BP measurements, measurement of cardiac output by pulse contour method, among others. Leading market players are continuously focusing on investing in research activities for new product developments and expanding their geographic reach to strengthen their position in the hemodynamic monitoring market. Some of the technological advancements are listed as below:

• In July 2022, Retia Medical received Series B funding of $15 million led by Fresenius Medical Care Ventures to expand its commercial team and accelerate the development and commercialization of its Argos Hemodynamic Monitor.
• In February 2022, Caretaker Medical received the US Food and Drug Administration (FDA) clearance to add four new parameters on its next-generation VitalStream wireless ‘beat-by-beat’ blood pressure and hemodynamic monitoring platform, to include stroke volume, cardiac output, left ventricular ejection time, and heart rate variability.
• In March 2021, Philips introduced its interventional hemodynamic system featuring a patient monitor- IntelliVue X3 to provide advanced hemodynamic measurements and improve patient focus during image-guided procedures.

Rising prevalence of cardiovascular diseases to boost the adoption of Hemodynamic Monitoring Market

Advanced hemodynamic monitoring methods have the ability to enhance the monitoring of cardiac patients during post-operative care and anesthesia providing precise and repeatable measurements to detect hemodynamic abnormalities and their causes. Cardiovascular diseases are one of the major causes of death all across the world. Coronary heart disease, cerebrovascular disease, rheumatic heart disease, and other illnesses are among the group of heart and blood vessel disorders known as CVDs.

Competitive Landscape Analysis: Hemodynamic Monitoring Market

The global hemodynamic monitoring market is marked by the presence of established market players such as Edwards Lifesciences ; Getinge ; LiDCO Group PLC ; Philips Healthcare SL ; ICU Medical ; and others.

?According to WHO, 32% of all deaths across the globe i.e., 17.9 million people die due to CVD every year.

As per CDC,

• 659,000 people in the US die from heart disease every year; heart diseases costs $363 billion each year in the US which includes cost of medicines and healthcare services.
• Coronary heart disease alone killed 360,900 people in 2019 in the US and over 18.2 million adults suffering from coronary artery disease live in USA.
• 805,000 people suffer from heart attack in the US every year of which 605,000 are a first heart attack while 200,000 happen to people already had a heart attack.
• According to European Heart Network, CVDs account for over 3.9 million deaths every year in the European region, out of which over 1.8 million deaths occur in the European Union (EU).

Get Detailed Insights on Hemodynamic Monitoring Market with Sample Report @ https://meditechinsights.com/hemodynamic-monitoring-market/

#hemodynamicmonitoring #hemodynamicmonitoringsystem #medicaldevices #medicalequipments #cardiovasculardisease #copd #respiratory #respiratorycare #surgical #surgicalequipment #noninvasivetreatment #patientcare #perfusion #oxygenation #anesthesia #healthcare #medicalcare